Stockreport

Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company's Portfolio [Yahoo! Finance]

Annovis Bio, Inc.  (ANVS) 
PDF for neurodegenerative diseases, announced the filing of a patent application covering the use of buntanetap and its analogues for the treatment of neuropsychiatric indic [Read more]